Feinberg School of Medicine, Northwestern University Chicago, IL
Elizabeth Johnson, MA1, Lobna Eldasher, PharmD1, Parambir S. Dulai, MD2 1RMEI, Voorhees, NJ; 2Feinberg School of Medicine, Northwestern University, Chicago, IL
Introduction: Despite the growing availability of advanced medical therapies for inflammatory bowel disease (IBD), significant gaps remain in treatment initiation. Targeted education and point-of-care clinical decision support may address this gap and lead to improved patient outcomes.
Methods: A multi-phase IBD focused provider education and decision support program spanning 10 years was developed consisting of: 1) symposia based education (n=1101 learners; 2014 to 2019), 2) point-of-care education (n=8547 learners) with clinical decision support tool (CDST) deployment (n=11,940 users, n=954 learners; 2019 to 2023), and 3) data driven platform optimization (2024). Modifications were made through qualitative learner and user surveys, crowdsourced cases to guide implementation, and quantitative data metrics. A matched pre-post methodology for testing was used for learners, and a key outcome measure was impact on mastery defined as correctness and confidence for scenario-based questions.
Results: Symposia-based education significantly improved provider knowledge, competence, and confidence for all learning domains except shared decision making and treatment selection. Based on learner data and qualitative provider feedback, a freely accessible web-based platform was launched (IBD CDST; www.CDSTforIBD.com). The platform had significant positive impacts on knowledge, competence, confidence, practice, and clinical decision-making learning domains, including shared decision making. A greater than 200% increase in mastery was observed because of the educational platform model. The impact was consistent for physicians and advanced practice providers.
Discussion: We have built a freely accessible web-based decision support tool platform for advanced medical therapy selection in IBD that significantly improved provider mastery in decision making for advanced medical therapies.
Disclosures:
Elizabeth Johnson indicated no relevant financial relationships.
Lobna Eldasher indicated no relevant financial relationships.
Elizabeth Johnson, MA1, Lobna Eldasher, PharmD1, Parambir S. Dulai, MD2. P2546 - Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease, ACG 2024 Annual Scientific Meeting Abstracts. Philadelphia, PA: American College of Gastroenterology.